Skip to main content
. 2021 Jun 30;29(8):843–856. doi: 10.1016/j.jsps.2021.06.006

Fig. 4.

Fig. 4

A-B) Evaluation of SRF solution, GA solution, SRF + GA solution and SRF with GA-loaded NLC formulation at various levels after the incubation of HEPG2 for 24 h and 48 h; Data expressed as mean ± S.D. (n = 6) (SRF; Sorafenib: GA; Ganoderic Acid: NLC; Nano lipid carriers).